{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:00:10Z","timestamp":1789124410878,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00259-008-1037-1","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T08:02:09Z","timestamp":1232438529000},"page":"702-714","source":"Crossref","is-referenced-by-count":77,"title":["Nuclear imaging in cardiac amyloidosis"],"prefix":"10.1007","volume":"36","author":[{"given":"A. W. J. M.","family":"Glaudemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H. J. A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"Zeebregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. C.","family":"Veltman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A.","family":"Tio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P. C.","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. A. J. O.","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,1,21]]},"reference":[{"issue":"22","key":"1037_CR1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","volume":"50","author":"JB Selvanayagam","year":"2007","unstructured":"Selvanayagam JB, Hawkins PN, Paul B, et al. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007;50(22):2101\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1037_CR2","first-page":"121","volume":"62","author":"BP Hazenberg","year":"2004","unstructured":"Hazenberg BP, van Gameren II, Bijzet J, et al. Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med 2004;62(4):121\u20138.","journal-title":"Neth J Med"},{"issue":"1","key":"1037_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506120500032196","volume":"12","author":"P Westermark","year":"2005","unstructured":"Westermark P, Benson MD, Buxbaum JN, et al. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid 2005;12(1):1\u20134.","journal-title":"Amyloid"},{"key":"1037_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","volume":"91","author":"SW Dubrey","year":"1998","unstructured":"Dubrey SW, Cha K, Anderson J, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998;91:141\u201357.","journal-title":"QJM"},{"key":"1037_CR5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9149(97)89403-9","volume":"77","author":"SW Dubrey","year":"1996","unstructured":"Dubrey SW, Cha K, Simms RW, et al. Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis. Am J Cardiol 1996;77:313\u20135.","journal-title":"Am J Cardiol"},{"key":"1037_CR6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.berh.2003.09.001","volume":"17","author":"MD Benson","year":"2003","unstructured":"Benson MD. The hereditary amyloidosis. Best Pract Res Clin Rheumatol 2003;17:909\u201327.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1037_CR7","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/archinte.165.12.1425","volume":"165","author":"B Ng","year":"2005","unstructured":"Ng B, Connors LH, Davidoff R, et al. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005;165:1425\u20139.","journal-title":"Arch Intern Med"},{"issue":"1","key":"1037_CR8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.copbio.2007.01.002","volume":"18","author":"V Camacho","year":"2007","unstructured":"Camacho V, Carrio I. Targeting neuronal dysfunction and receptor imaging. Curr Opin Biotechnol 2007;18(1):60\u20134.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"1037_CR9","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1067\/mhj.2002.123115","volume":"144","author":"M Hongo","year":"2002","unstructured":"Hongo M, Urushibata K, Kai R, et al. Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis. Am Heart J 2002;144(1):122\u20139.","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"1037_CR10","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1007\/s00259-007-0441-2","volume":"34","author":"S Yamashina","year":"2007","unstructured":"Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 2007;34(Suppl 1):S62\u201373.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1037_CR11","first-page":"1040","volume":"36","author":"T Nakata","year":"1995","unstructured":"Nakata T, Shimamoto K, Yonekura S, et al. Cardiac sympathetic denervation in transthyretin-related familial amyloidotic polyneuropathy: detection with iodine-12-MIBG. J Nucl Med 1995;36(6):1040\u20132.","journal-title":"J Nucl Med"},{"issue":"2","key":"1037_CR12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF03164822","volume":"11","author":"AS Arbab","year":"1997","unstructured":"Arbab AS, Koizumi K, Toyama K, et al. Scan findings of various myocardial SPECT agents in a case of amyloid polyneuropathy with suspected myocardial involvement. Ann Nucl Med 1997;11(2):139\u201341.","journal-title":"Ann Nucl Med"},{"issue":"1","key":"1037_CR13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","volume":"29","author":"M Tanaka","year":"1997","unstructured":"Tanaka M, Hongo M, Kinoshita O, et al. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1997;29(1):168\u201374.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1037_CR14","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s002590050406","volume":"26","author":"N Delahaye","year":"1999","unstructured":"Delahaye N, Dinanian S, Slama MS, et al. Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability. Eur J Nucl Med 1999;26(4):416\u201324.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"1037_CR15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/13506120309041733","volume":"10","author":"J Lekakis","year":"2003","unstructured":"Lekakis J, Dimopoulos MA, Prassopoulos V, et al. Myocardial adrenergic denervation in patients with primary (AL) amyloidosis. Amyloid 2003;10(2):117\u201320.","journal-title":"Amyloid"},{"issue":"4","key":"1037_CR16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/01.md.0000232559.22098.c3","volume":"85","author":"N Delahaye","year":"2006","unstructured":"Delahaye N, Rouzet F, Sarda L, et al. Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 2006;85(4):229\u201338.","journal-title":"Medicine (Baltimore)"},{"key":"1037_CR17","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1161\/hc4901.100380","volume":"104","author":"N Delahaye","year":"2001","unstructured":"Delahaye N, Le Guludec D, Dinanian S, et al. Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation 2001;104:2911\u20136.","journal-title":"Circulation"},{"issue":"2","key":"1037_CR18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.81.2.153","volume":"81","author":"Y Yazaki","year":"1999","unstructured":"Yazaki Y, Isobe M, Takahashi W, et al. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123 I BMIPP SPECT: correlation with clinicopathological findings and clinical course. Heart 1999;81(2):153\u20139.","journal-title":"Heart"},{"key":"1037_CR19","first-page":"283","volume":"21","author":"F Geeter De","year":"1994","unstructured":"De Geeter F, Franken PR, Knapp FF, et al. Relationship between blood flow and fatty acid metabolism in subacute myocardial infarction: a study by means of 99mTc-Sestamibi and I-beta-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med 1994;21:283\u201391.","journal-title":"Eur J Nucl Med"},{"key":"1037_CR20","first-page":"1758","volume":"35","author":"PR Franken","year":"1994","unstructured":"Franken PR, De Geeter F, Dendale P, et al. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve. J Nucl Med 1994;35:1758\u201365.","journal-title":"J Nucl Med"},{"key":"1037_CR21","first-page":"1679","volume":"37","author":"T Nakata","year":"1996","unstructured":"Nakata T, Tanaka S, Hamagami S, et al. Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP. J Nucl Med 1996;37:1679\u201381.","journal-title":"J Nucl Med"},{"issue":"9","key":"1037_CR22","first-page":"1468","volume":"40","author":"AS Hambye","year":"1999","unstructured":"Hambye AS, Dobbeleir AA, Vervaet AM, et al. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction. J Nucl Med 1999;40(9):1468\u201376.","journal-title":"J Nucl Med"},{"issue":"8","key":"1037_CR23","first-page":"631","volume":"28","author":"T Athanasoulis","year":"2003","unstructured":"Athanasoulis T, Koutsikos J, Moulopoulos LA, et al. Reverse of the differential uptake intensity of Tc-99m MIBI and Tc-99m V-DMSA by multiple myeloma lesions in response to therapy. Clin Nucl Med 2003;28(8):631\u20135.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"1037_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/bcr751","volume":"6","author":"VJ Papantoniou","year":"2003","unstructured":"Papantoniou VJ, Souvatzoglou MA, Valotassiou VJ, et al. Relationship of cell proliferation (Ki-67) to 99mTc-(V) DMSA uptake in breast cancer. Br Cancer Res 2003;6(2):56\u201362.","journal-title":"Br Cancer Res"},{"issue":"5","key":"1037_CR25","first-page":"815","volume":"34","author":"H Kobayashi","year":"1993","unstructured":"Kobayashi H, Sakahara H, Itoh T, et al. Technetium-99m(V)dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein. J Nucl Med 1993;34(5):815\u20137.","journal-title":"J Nucl Med"},{"issue":"12","key":"1037_CR26","first-page":"2049","volume":"30","author":"H Ohta","year":"1989","unstructured":"Ohta H, Endo K, Kanoh T, et al. Technetium-99m (V) DMSA uptake in amyloidosis. J Nucl Med 1989;30(12):2049\u201352.","journal-title":"J Nucl Med"},{"issue":"1","key":"1037_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/PL00006663","volume":"27","author":"TC Yen","year":"2000","unstructured":"Yen TC, Tzen KY, Chen KS, et al. The value of gallium-67 and thallium-201 whole-body and single-photon emission tomography images in dialysis-related \u03b22-microglobulin amyloid. Eur J Nucl Med 2000;27(1):56\u201361.","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"1037_CR28","first-page":"898","volume":"24","author":"YH Low","year":"1995","unstructured":"Low YH, Ang ES, Goh AS, et al. Technetium-99m (Tc-99m) diphosphono-propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis \u2013 a case report. Ann Acad Med Singapore 1995;24(6):898\u2013901.","journal-title":"Ann Acad Med Singapore"},{"issue":"5","key":"1037_CR29","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.nuclcard.2007.07.002","volume":"14","author":"K Wechalekar","year":"2007","unstructured":"Wechalekar K, Ng FS, Poole-Wilson PA, et al. Cardiac amyloidosis diagnosed incidentally by bone scintigraphy. J Nucl Cardiol 2007;14(5):750\u20133.","journal-title":"J Nucl Cardiol"},{"issue":"4","key":"1037_CR30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF03164710","volume":"7","author":"T Kobayashi","year":"1993","unstructured":"Kobayashi T, Sekiya M, Fujiwara Y, et al. A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation. Ann Nucl Med 1993;7(4):273\u20136.","journal-title":"Ann Nucl Med"},{"issue":"5","key":"1037_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/A:1006210913708","volume":"15","author":"K Kodama","year":"1999","unstructured":"Kodama K, Hamada M, Kuwahara T, et al. Rest-redistribution thallium-201 myocardial scintigraphic study in cardiac amyloidosis. Int J Card Imaging 1999;15(5):371\u20138.","journal-title":"Int J Card Imaging"},{"issue":"6","key":"1037_CR32","doi-asserted-by":"crossref","first-page":"535\u22129","DOI":"10.1097\/00006231-200506000-00009","volume":"26","author":"SM Sojan","year":"2005","unstructured":"Sojan SM, Smyth DR, Tsopelas C, et al. Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin. Nucl Med Commun 2005;26(6):535\u22129.","journal-title":"Nucl Med Commun"},{"issue":"12","key":"1037_CR33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","volume":"22","author":"C Aprile","year":"1995","unstructured":"Aprile C, Marinone G, Saponaro R, et al. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin. Eur J Nucl Med 1995;22(12):1393\u2013401.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"1037_CR34","first-page":"177","volume":"44","author":"BK Schaadt","year":"2003","unstructured":"Schaadt BK, Hendel HW, Gimsing P, et al. 99mTc-aprotinin scintigraphy in amyloidosis. J Nucl Med 2003;44(2):177\u201383.","journal-title":"J Nucl Med"},{"issue":"6","key":"1037_CR35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0609.2007.00963.x","volume":"79","author":"S Han","year":"2007","unstructured":"Han S, Chong V, Murray T, et al. Preliminary experience of 99mTc-aprotinin scintigraphy in amyloidosis. Eur J Haematol 2007;79(6):494\u2013500.","journal-title":"Eur J Haematol"},{"issue":"8002","key":"1037_CR36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0140-6736(77)91102-3","volume":"1","author":"RW Kula","year":"1977","unstructured":"Kula RW, Engel WK, Line BR. Scanning for soft-tissue amyloid. Lancet 1977;1(8002):92\u20133.","journal-title":"Lancet"},{"issue":"3","key":"1037_CR37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00259-001-0730-0","volume":"29","author":"M Puille","year":"2002","unstructured":"Puille M, Altland K, Linke RP, et al. 99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy. Eur J Nucl Med Mol Imaging 2002;29(3):376\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1037_CR38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0167-5273(87)90209-9","volume":"14","author":"K Karp","year":"1987","unstructured":"Karp K, Naslund U, Backman C, et al. Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy. Int J Cardiol 1987;14(3):365\u20139.","journal-title":"Int J Cardiol"},{"issue":"2","key":"1037_CR39","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0002-9149(84)90481-8","volume":"53","author":"H Leinonen","year":"1984","unstructured":"Leinonen H, Totterman KJ, Korppi-Tommola T, et al. Negative myocardial technetium-99m pyrophosphate scintigraphy in amyloid heart disease associated with type AA systemic amyloidosis. Am J Cardiol 1984;53(2):380\u20131.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1037_CR40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1023608115278","volume":"19","author":"J Kulhanek","year":"2003","unstructured":"Kulhanek J, Movahed A. Uptake of technetium 99m HDP in cardiac amyloidosis. Int J Cardiovasc Imaging 2003;19(3):225\u20137.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"7","key":"1037_CR41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/01.rlu.0000167664.47995.d9","volume":"30","author":"D Casset-Senon","year":"2005","unstructured":"Casset-Senon D, Secchi V, Arbeille P, et al. Localization of myocardial amyloid deposits in cardiac amyloidosis by Tc-99m pyrophosphate myocardial SPECT: implication for medical treatment. Clin Nucl Med 2005;30(7):496\u20137.","journal-title":"Clin Nucl Med"},{"issue":"8","key":"1037_CR42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0002-9149(84)80170-8","volume":"54","author":"RH Falk","year":"1984","unstructured":"Falk RH, Lee VW, Rubinow A, et al. Cardiac technetium-99m pyrophosphate scintigraphy in familial amyloidosis. Am J Cardiol 1984;54(8):1150\u20131.","journal-title":"Am J Cardiol"},{"issue":"7","key":"1037_CR43","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00007611-198407000-00010","volume":"77","author":"MA Ruder","year":"1984","unstructured":"Ruder MA, Alpert MA, Sanfelippo JF, et al. Symptomatic cardiac amyloidosis in an American family. South Med J 1984;77(7):831\u20133.","journal-title":"South Med J"},{"issue":"4 Pt 1","key":"1037_CR44","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-8703(82)90344-1","volume":"103","author":"SM Sobol","year":"1982","unstructured":"Sobol SM, Brown JM, Bunker SR, et al. Noninvasive diagnosis of cardiac amyloidosis by technetium-99m-pyrophosphate myocardial scintigraphy. Am Heart J 1982;103(4 Pt 1):563\u20136.","journal-title":"Am Heart J"},{"issue":"4 Pt 1","key":"1037_CR45","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0002-8703(82)90343-X","volume":"103","author":"S Schiff","year":"1982","unstructured":"Schiff S, Bateman T, Moffatt R, et al. Diagnostic considerations in cardiomyopathy: unique scintigraphic pattern of diffuse biventricular technetium-99m-pyrophosphate uptake in amyloid heart disease. Am Heart J 1982;103(4 Pt 1):562\u20133.","journal-title":"Am Heart J"},{"issue":"3","key":"1037_CR46","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00003072-198103000-00003","volume":"6","author":"A Ali","year":"1981","unstructured":"Ali A, Turner DA, Rosenbush SW, et al. Bone scintigram in cardiac amyloidosis: a case report. Clin Nucl Med 1981;6(3):105\u20138.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"1037_CR47","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/00003072-200010000-00019","volume":"25","author":"I Ak","year":"2000","unstructured":"Ak I, Vardareli E, Erdinc O, et al. Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement. Clin Nucl Med 2000;25(10):826\u20137.","journal-title":"Clin Nucl Med"},{"issue":"11","key":"1037_CR48","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0002-9149(93)91085-V","volume":"72","author":"C Fournier","year":"1993","unstructured":"Fournier C, Grimon G, Rinaldi JP, et al. Usefulness of technetium-99m pyrophosphate myocardial scintigraphy in amyloid polyneuropathy and correlation with echocardiography. Am J Cardiol 1993;72(11):854\u20137.","journal-title":"Am J Cardiol"},{"issue":"3","key":"1037_CR49","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/0002-8703(87)90703-4","volume":"113","author":"M Hongo","year":"1987","unstructured":"Hongo M, Hirayama J, Fujii T, et al. Early identification of amyloid heart disease by technetium-99m-pyrophosphate scintigraphy: a study with familial amyloid polyneuropathy. Am Heart J 1987;113(3):654\u201362.","journal-title":"Am Heart J"},{"issue":"10","key":"1037_CR50","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/00003072-199310000-00007","volume":"18","author":"RM Davidson","year":"1993","unstructured":"Davidson RM, Lin DS, Klima M. Temporal changes in myocardial uptake on serial bone scans in two cases of presumed senile cardiac amyloidosis. Clin Nucl Med 1993;18(10):858\u201362.","journal-title":"Clin Nucl Med"},{"issue":"11","key":"1037_CR51","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0002-9149(89)90267-1","volume":"63","author":"SA Goldstein","year":"1989","unstructured":"Goldstein SA, Lindsay J, Chandeysson PL, et al. Usefulness of technetium pyrophosphate scintigraphy in demonstrating cardiac amyloidosis in persons aged 85\u00a0years and older. Am J Cardiol 1989;63(11):752\u20133.","journal-title":"Am J Cardiol"},{"issue":"4 Pt 1","key":"1037_CR52","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0002-8703(82)90331-3","volume":"103","author":"TA Wizenberg","year":"1982","unstructured":"Wizenberg TA, Muz J, Sohn YH, et al. Value of positive myocardial technetium-99m-pyrophosphate scintigraphy in the non-invasive diagnosis of cardiac amyloidosis. Am Heart J 1982;103(4 Pt 1):468\u201373.","journal-title":"Am Heart J"},{"issue":"5","key":"1037_CR53","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0002-9149(83)80140-4","volume":"51","author":"RH Falk","year":"1983","unstructured":"Falk RH, Lee VW, Rubinow A. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis. Am J Cardiol 1983;51(5):826\u201330.","journal-title":"Am J Cardiol"},{"issue":"1","key":"1037_CR54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1148\/radiology.148.1.6304810","volume":"148","author":"VW Lee","year":"1983","unstructured":"Lee VW, Caldarone AG, Falk RH, et al. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection. Radiology 1983;148(1):239\u201342.","journal-title":"Radiology"},{"issue":"3","key":"1037_CR55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/hrt.52.3.321","volume":"52","author":"P Eriksson","year":"1984","unstructured":"Eriksson P, Backman C, Bjerle P, et al. Non-invasive assessment of the presence and severity of cardiac amyloidosis. A study in familial amyloidosis with polyneuropathy by cross sectional echocardiography and technetium-99m pyrophosphate scintigraphy. Br Heart J 1984;52(3):321\u20136.","journal-title":"Br Heart J"},{"issue":"8-10","key":"1037_CR56","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF00998166","volume":"16","author":"S Janssen","year":"1990","unstructured":"Janssen S, Piers DA, van Rijswijk MH, et al. Soft-tissue uptake of 99mTc-diphosphonate and 99mTc-pyrophosphate in amyloidosis. Eur J Nucl Med 1990;16(8-10):663\u201370.","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"1037_CR57","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01797839","volume":"5","author":"A Hartmann","year":"1990","unstructured":"Hartmann A, Frenkel J, Hopf R, et al. Is technetium-99m-pyrophosphate scintigraphy valuable in the diagnosis of cardiac amyloidosis? Int J Card Imaging 1990;5(4):227\u201331.","journal-title":"Int J Card Imaging"},{"issue":"6","key":"1037_CR58","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E, Guidalotti PL, Salvi F, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46(6):1076\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1037_CR59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0031-6997(24)01383-8","volume":"50","author":"LR Bernstein","year":"1998","unstructured":"Bernstein LR. Mechanisms of therapeutic activity for gallium. Pharm Rev 1998;50(4):665\u201382.","journal-title":"Pharm Rev"},{"issue":"6","key":"1037_CR60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00003072-197906000-00008","volume":"4","author":"SD Braun","year":"1979","unstructured":"Braun SD, Lisbona R, Novales-Diaz JA, et al. Myocardial uptake of 99mTc-phosphate tracer in amyloidosis. Clin Nucl Med 1979;4(6):244\u20135.","journal-title":"Clin Nucl Med"},{"issue":"9","key":"1037_CR61","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/BF00295583","volume":"9","author":"J Montes","year":"1984","unstructured":"Montes J, Lopez L, Chamorro JL, et al. Cardiac gallium uptake in amyloidosis. Eur J Nucl Med 1984;9(9):438.","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"1037_CR62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00003072-198503000-00004","volume":"10","author":"CK Li","year":"1985","unstructured":"Li CK, Rabinovitch MA, Juni JE, et al. Scintigraphic characterization of amyloid cardiomyopathy. Clin Nucl Med 1985;10(3):156\u20139.","journal-title":"Clin Nucl Med"},{"key":"1037_CR63","first-page":"231","volume":"31","author":"D Jain","year":"1990","unstructured":"Jain D, Crawly JC, Lahiri A, et al. Indium-111 antimyosin images compared with triphenyltetrazolium chloride staining in a patient six days after myocardial infarction. J Nucl Med 1990;31:231\u20133.","journal-title":"J Nucl Med"},{"key":"1037_CR64","first-page":"1893","volume":"29","author":"I Carrio","year":"1988","unstructured":"Carrio I, Berna L, Ballester M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988;29:1893\u2013900.","journal-title":"J Nucl Med"},{"key":"1037_CR65","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02262734","volume":"18","author":"J Lekakis","year":"1991","unstructured":"Lekakis J, Vassipoulos N, Psichoyiou H, et al. Doxorubicin cardiotoxicity detected by indium-111 myosin specific imaging. Eur J Nucl Med 1991;18:225\u20136.","journal-title":"Eur J Nucl Med"},{"key":"1037_CR66","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0002-8703(92)90085-A","volume":"124","author":"J Lekakis","year":"1992","unstructured":"Lekakis J, Nanas J, Moustafellou C, et al. Cardiac amyloidosis detected by indium-111 antimyosin imaging. Am Heart J 1992;124:1630\u20131.","journal-title":"Am Heart J"},{"key":"1037_CR67","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0002-9149(97)00558-4","volume":"80","author":"J Lekakis","year":"1997","unstructured":"Lekakis J, Dimopoulos M, Nanas J, et al. Antimyosin scintigraphy for detection of cardiac amyloidosis. Am J Cardiol 1997;80:963\u20135.","journal-title":"Am J Cardiol"},{"key":"1037_CR68","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0735-1097(89)90252-0","volume":"13","author":"CN Aroney","year":"1989","unstructured":"Aroney CN, Ruddy TD, Dighero H, et al. Differentiation of restrictive cardiomyopathy from pericardial constriction: assessment of diastolic function by radionuclide angiography. J Am Coll Cardiol 1989;13:1007\u201314.","journal-title":"J Am Coll Cardiol"},{"key":"1037_CR69","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0002-8703(89)90080-X","volume":"118","author":"MC Gerson","year":"1989","unstructured":"Gerson MC, Colthar MS, Fowler NO. Differentiation of constrictive pericarditis and restrictive cardiomyopathy by radionuclide ventriculography. Am Heart J 1989;118:114\u201320.","journal-title":"Am Heart J"},{"key":"1037_CR70","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00006231-200001000-00010","volume":"21","author":"IP Clements","year":"2000","unstructured":"Clements IP, Olson LJ, Scanlon PD, et al. The effect of respiration on left ventricular diastolic filling as assessed by radionuclide ventriculography. Nucl Med Commun 2000;21:55\u201363.","journal-title":"Nucl Med Commun"},{"key":"1037_CR71","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(89)90547-0","volume":"13","author":"M Hongo","year":"1989","unstructured":"Hongo M, Fujii T, Hirayama J, et al. Radionuclide angiographic assessment of left ventricular diastolic filling in amyloid heart disease: a study of patients with familial amyloid polyneuropathy. J Am Coll Cardiol 1989;13:48\u201353.","journal-title":"J Am Coll Cardiol"},{"key":"1037_CR72","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1161\/01.CIR.0000068314.02595.B2","volume":"107","author":"G Palladini","year":"2003","unstructured":"Palladini G, Campana C, Klersy C, et al. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis. Circulation 2003;107:2440\u20135.","journal-title":"Circulation"},{"issue":"6","key":"1037_CR73","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","volume":"104","author":"A Dispenzieri","year":"2004","unstructured":"Dispenzieri A, Gertz MA, Kyle RA, et al. Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation. Blood 2004;104(6):1881\u20137.","journal-title":"Blood"},{"key":"1037_CR74","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","volume":"323","author":"PN Hawkins","year":"1990","unstructured":"Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med 1990;323:508\u201313.","journal-title":"N Engl J Med"},{"key":"1037_CR75","doi-asserted-by":"crossref","first-page":"355.e15","DOI":"10.1016\/j.amjmed.2005.08.043","volume":"119","author":"BP Hazenberg","year":"2006","unstructured":"Hazenberg BP, van Rijswijk MH, Piers DA, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med 2006;119:355.e15\u2013e24.","journal-title":"Am J Med"},{"key":"1037_CR76","first-page":"699","volume":"39","author":"PL Jager","year":"1998","unstructured":"Jager PL, Hazenberg BP, Franssen EJF, et al. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value. J Nucl Med 1998;39:699\u2013706.","journal-title":"J Nucl Med"},{"issue":"6","key":"1037_CR77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2967\/jnumed.106.039313","volume":"48","author":"BP Hazenberg","year":"2007","unstructured":"Hazenberg BP, Van Rijswijk MH, Lub-de Hooge M, et al. Diagnostic performance and prognostic value of extravascular retention of 123I-labeled serum amyloid P component in systemic amyloidosis. J Nucl Med 2007;48(6):865\u201372.","journal-title":"J Nucl Med"},{"key":"1037_CR78","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1749-8090-1-32","volume":"1","author":"S Yadav","year":"2006","unstructured":"Yadav S, Sharma S, Gilfillan I. Unusual positron emission tomography findings in pulmonary amyloidosis: a case report. J Cardiothorac Surg 2006;1:32.","journal-title":"J Cardiothorac Surg"},{"issue":"3","key":"1037_CR79","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B. Ann Neurol 2004;55(3):306\u201319.","journal-title":"Ann Neurol"},{"key":"1037_CR80","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/01.wnl.0000259035.98480.ed","volume":"68","author":"GD Rabinovici","year":"2007","unstructured":"Rabinovici GD, Furst AJ, O\u2019Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007;68:1205\u201312.","journal-title":"Neurology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-008-1037-1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T02:10:37Z","timestamp":1738894237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-008-1037-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,21]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1007\/s00259-008-1037-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,21]]}}}